Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR007429)
Formula
SVG example
N-dealkylation
Reactant CYC-202 Product CYC-202 M2
Reactant Info Product Info
Metabolic Type Oxidation - N-dealkylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007428 CYC-202 CYC-202 M1 Oxidation - Oxidationn CYC-202 [1]
MR007430 CYC-202 CYC-202 M3 Oxidation - Oxidationn CYC-202 [1]
MR007431 CYC-202 CYC-202 M4 Oxidation - N-dealkylation CYC-202 [1]
MR007432 CYC-202 CYC-202 M5 Oxidation - Oxidationn CYC-202 [1]
MR007435 CYC-202 CYC-202 M6 Conjugation - Glucuronidation CYC-202 [1]
MR007436 CYC-202 CYC-202 M7 Unclear CYC-202 [1]
MR007433 CYC-202 Met-4 Unclear CYC-202 [1]
MR007434 CYC-202 PMF30-128 Unclear CYC-202 [1]
References
1 Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo. Drug Metab Dispos. 2008 Mar;36(3):561-70.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.